Sustainable production of plant-derived bioactives via genetic engineering and nanotechnology-driven approaches

As the global demand for plant-based bioactives rises, fuelled by concerns about synthetic drugs and sustainability, there is urgent need for advanced metabolic engineering solutions. Conventional extraction methods, however, are limited by low yields, seasonal variabilities and environmental impact. This review critically examines sustainable production strategies that combine the potential of CRISPR-based gene editing, nanoparticle mediated delivery systems, elicitation techniques and metabolic flux regulation to enhance the secondary metabolite production in plants. Recent advances have enabled targeted pathway redirection, achieving multi-fold increases in compounds such as artemisinin, paclitaxel and reservatol in both model and medicinal species. Nanoparticle-mediated elicitation and nano-delivery of CRISPR components further enhance metabolic flux and precise genetic alterations to boost metabolite biosynthesis. Although challenges related to biological and experimental limitations including species-specific responses, incomplete pathway elucidation and off target editing remain. Technological barriers encompass scalability constraints in bioreactors, nanoparticle aggregation, phytotoxicity and regulatory hurdles involving absence of harmonised frameworks for genome-edited and nanomaterial exposed crops for pharma use. This review offers the realistic roadmap for fusion of nanotechnology with metabolite engineering for paving the way for innovations in agriculture, pharmaceuticals and industrial biotechnology, promoting more efficient and environmentally friendly production of bioactive compounds. • CRISPR/Cas enables precise edits to boost metabolite biosynthesis. • Nanoparticles enhance enzyme activity and precursor delivery. • Metabolic flux regulation improves secondary metabolite yields. • Synthetic biology advances support scalable bioactive production. • Integration of nanotech and genetics drives sustainable innovation.

Authors

Institutions

Publication Details

Journal
Current Plant Biology
Published
2026-04-01
DOI
https://doi.org/10.1016/j.cpb.2026.100607
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sustainable production of plant-derived bioactives via genetic engineering and nanotechnology-driven approaches

Pravej Alam, Pooja Sharma, Sanamdeep Singh, Mohammad Faizan et al.
Current Plant Biology
CRISPR and Genetic Engineering
article

Sustainable production of plant-derived bioactives via genetic engineering and nanotechnology-driven approaches

Pravej Alam, Pooja Sharma, Sanamdeep Singh, Mohammad Faizan, Thamer Albalwai
article en

Abstract

As the global demand for plant-based bioactives rises, fuelled by concerns about synthetic drugs and sustainability, there is urgent need for advanced metabolic engineering solutions. Conventional extraction methods, however, are limited by low yields, seasonal variabilities and environmental impact. This review critically examines sustainable production strategies that combine the potential of CRISPR-based gene editing, nanoparticle mediated delivery systems, elicitation techniques and metabolic flux regulation to enhance the secondary metabolite production in plants. Recent advances have enabled targeted pathway redirection, achieving multi-fold increases in compounds such as artemisinin, paclitaxel and reservatol in both model and medicinal species. Nanoparticle-mediated elicitation and nano-delivery of CRISPR components further enhance metabolic flux and precise genetic alterations to boost metabolite biosynthesis. Although challenges related to biological and experimental limitations including species-specific responses, incomplete pathway elucidation and off target editing remain. Technological barriers encompass scalability constraints in bioreactors, nanoparticle aggregation, phytotoxicity and regulatory hurdles involving absence of harmonised frameworks for genome-edited and nanomaterial exposed crops for pharma use. This review offers the realistic roadmap for fusion of nanotechnology with metabolite engineering for paving the way for innovations in agriculture, pharmaceuticals and industrial biotechnology, promoting more efficient and environmentally friendly production of bioactive compounds. • CRISPR/Cas enables precise edits to boost metabolite biosynthesis. • Nanoparticles enhance enzyme activity and precursor delivery. • Metabolic flux regulation improves secondary metabolite yields. • Synthetic biology advances support scalable bioactive production. • Integration of nanotech and genetics drives sustainable innovation.

Current Plant BiologyVol. 47
Prince Sattam Bin Abdulaziz University (SA), Maulana Azad National Urdu University (IN), Baba Farid University of Health Sciences (IN)
Openalex Percentile: Top 28%
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.